top of page

Title: Australia stocks higher at close of trade; S&P/ASX 200 up 0.16%

Writer: analysiswatchanalysiswatch

Feb 17, 2022 02:45 AM ET


By: AnalysisWatch


Australian shares rose after the close on Thursday as gains in the health care, gold, and industrial sectors drove stocks higher.


At the close in Sydney, the S & P/ASX 200 was up 0.16%.


The best performer on the S&P/ASX 200 was NRW Holdings Ltd., which rose 15.36%, or 0.26 points, to 1.99 at the close of trading.IPH Ltd rose 9.19% or 0.76 points to 9.03 and Challenger Ltd rose 6.65% or 0.420 points to 6.740 in late trade.


Wesfarmers Ltd was the worst performer, falling 7.48% or 4.110 points to trade at 50.810 at the close of trade. Pro Medicus Ltd fell 6.02%, or 2.89 points, to 45.11, while Domain Holdings Australia Ltd fell 6.22%, or 0.29 points, to 4.37.


On the Sydney Stock Exchange, falling stocks outweighed rising ones by 744 to 652, and 417 ended unchanged.


The S&P/ASX 200 VIX, which measures implied volatility of S&P/ASX 200 options, increased 1.25% to 15.305.


Gold futures for April delivery rose 0.33%, or $6.20, to $1877.70 a troy ounce. Elsewhere in commodities trading, crude oil for March delivery fell 1.10%, or 1.03, to $92.63 a barrel, while the April contract for Brent crude fell 1.18%, or 1.12, to $93.69 a barrel.


The AUD/USD pair rose 0.04% to 0.7195, while the AUD/JPY pair fell 0.14% to 82.92.


98.830. US dollar index futures rose 0.14% to 95.830.

 
 
 

Comments


2b94f773-a237-4da7-a599-6b42314ed9e6.png

Risk Disclosure: AnalysisWatch will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Currency trading on margin involves high risk, and is not suitable for all investors. Before deciding to trade foreign exchange or any other financial instrument you should carefully consider your investment objectives, level of experience, and risk appetite.
AnalysisWatch would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore AnalysisWatch doesn’t bear any responsibility for any trading losses you might incur as a result of using this data.

bottom of page